OPERAS Opioid-free Pain relief for Enhanced Recovery After Spine fixation surgery
- Coordinator
- Sentryx BV, Netherlands
- Runs
- 1 April 2023 to 31 March 2026
- Status
- Running
- EU funding
- €2.5m
- Total cost
- €5.7m
- Partners
- 1 organisations in 1 countries
- Type
- European Innovation Council
- Grant agreement
- 190122961
What the project is doing
In the project's own words, from its summary on CORDIS.
There is a troubling lack of effective pain treatments after major surgery. Especially after musculoskeletal procedures, patients experience debilitating pain now treated with opioids. Opioids provide insufficient pain relief, have many toxic side-effects, and are highly addictive. Pain and opioid-related side-effects impede early mobilisation and recovery and are the primary reasons for extended hospital stays. SentryX is developing revolutionary drug delivery technology to extend the effects of a well-established local pain blocker called bupivacaine.
Its initial use case in spine fixation surgery, Bupi-Ring, delivers bupivacaine directly to the surgical site for more than 72 hours without changing the existing surgical workflow. Non-opioid local pain relief in this critical early phase of recovery will promote early mobilisation, shorten hospital stays, prevent complications, and save costs. This project will demonstrate Bupi-Ring’s safety and efficacy in humans for the first time.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Sentryx BV | Austerlitz | Netherlands | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI